clonixin has been researched along with Innate Inflammatory Response in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (14.81) | 18.7374 |
1990's | 8 (29.63) | 18.2507 |
2000's | 1 (3.70) | 29.6817 |
2010's | 11 (40.74) | 24.3611 |
2020's | 3 (11.11) | 2.80 |
Authors | Studies |
---|---|
Edwards, BS; Graves, SW; Saunders, MJ; Sklar, LA; Zhu, J | 1 |
Greene, JM; Martinez, MN | 1 |
Bruckmaier, RM; Sintes, GF; Wellnitz, O | 1 |
Arthur, RM; Goldin, S; Gretler, SR; Kass, PH; Knych, HK; McKemie, DS | 1 |
Catala, M; Fournier, R; Roy, O; Thiry, J | 1 |
Fosse, TK; Levionnois, OL; Ranheim, B | 1 |
Johns, IC; Knowles, EJ; Linnenkohl, W; Mair, TS; Naylor, RJ; Taylor, AH; Wilford, S | 1 |
Freeman, DE | 1 |
Johns, I; Knowles, E; Linnenkohl, W; Mair, T; Naylor, R; Taylor, A; Wilford, S | 1 |
Baynes, RE; Dutko, T; Gehring, R; Herges, G; Li, M; Riviere, JE; Schroeder, JW; Shelver, WL; Smith, DJ; Tell, L | 1 |
Schneider, MJ; Shelver, WL; Smith, DJ | 1 |
Chiesa, OA; Deaver, C; Esparza, J; Jones, YL; Kenyon, E; Lancaster, V; Myers, MJ; Peters, SM; Screven, R; Stubbs, JT; Wiesenfeld, PL; Yancy, H; Yang, M | 1 |
Jeremejeva, J; Kask, K; Orro, T; Waldmann, A | 1 |
Cook, VL; Gandy, JC; Hauptman, JG; Holcombe, SJ; Jacobs, CC; Sordillo, LM | 1 |
Bryant, CE; Farnfield, BA; Janicke, HJ | 1 |
Higgins, AJ; Lees, P | 1 |
Snow, D | 1 |
Cunningham, FM; Landoni, MF; Lees, P | 1 |
Dalle, S; Daval, S; Espinasse, J; Garcia, J; Salat, O; Schelcher, F; Thouvenot, JP; Valarcher, JF | 1 |
Landoni, MF; Lees, P | 1 |
Magnusson, U; Odensvik, K | 1 |
Headley, PM; Herrero, JF | 1 |
Cheng, Z; Lees, P; McKellar, Q; Nolan, A | 1 |
Cheng, Z; McKellar, QA; Nolan, AM | 1 |
Cheng, Z; McKeller, Q; Nolan, A | 1 |
Higgins, AJ; Lees, P; Sharma, SC; Taylor, JB | 1 |
Krohne, SD; Vestre, WA | 1 |
4 trial(s) available for clonixin and Innate Inflammatory Response
Article | Year |
---|---|
PK/PD modeling of flunixin meglumine in a kaolin-induced inflammation model in piglets.
Topics: Analgesics; Animals; Animals, Newborn; Anti-Inflammatory Agents; Clonixin; Disease Models, Animal; Dose-Response Relationship, Drug; Inflammation; Injections, Intravenous; Kaolin; Pain Measurement; Swine | 2018 |
Comparison of flunixin meglumine and meloxicam for post operative management of horses with strangulating small intestinal lesions.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Clonixin; Endotoxins; Female; Horse Diseases; Horses; Inflammation; Intestinal Obstruction; Intestine, Small; Male; Meloxicam; Postoperative Complications; Thiazines; Thiazoles | 2014 |
Treatment of dairy cows with PGF2α or NSAID, in combination with antibiotics, in cases of postpartum uterine inflammation.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Cattle Diseases; Cephalosporins; Clonixin; Dairying; Dinoprost; Drug Combinations; Endometritis; Estonia; Female; Fertility; Inflammation; Postpartum Period; Puerperal Infection | 2012 |
Effect of oral administration of flunixin meglumine on the inflammatory response to endotoxin in heifers.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Temperature; Cattle; Cattle Diseases; Clonixin; Dinoprost; Endotoxins; Escherichia coli; Female; Hydrocortisone; Inflammation; Injections, Intravenous; Leukocyte Count; Leukocytes, Mononuclear; Neutrophils | 1996 |
23 other study(ies) available for clonixin and Innate Inflammatory Response
Article | Year |
---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature | 2010 |
Using simulations to explore the potential effect of disease and inflammation on the frequency of violative flunixin residues in cattle.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Cattle Diseases; Clonixin; Drug Residues; Inflammation; Liver | 2023 |
Nonsteroidal anti-inflammatory drugs affect the mammary epithelial barrier during inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Cell Count; Clonixin; Cyclooxygenase Inhibitors; Epithelial Cells; Escherichia coli; Female; Inflammation; Ketoprofen; Lipopolysaccharides; Mammary Glands, Animal; Mastitis, Bovine; Meloxicam; Milk; Tumor Necrosis Factor-alpha | 2020 |
Pharmacokinetics of transdermal flunixin meglumine and effects on biomarkers of inflammation in horses.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Cattle; Chromatography, Liquid; Clonixin; Horse Diseases; Horses; Inflammation; Tandem Mass Spectrometry | 2021 |
Evaluation of flunixin meglumine pour-on administration on prostaglandin E
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Cattle Diseases; Clonixin; Dinoprostone; Exudates and Transudates; Inflammation; Random Allocation | 2017 |
Letter to the editor.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Clonixin; Female; Horse Diseases; Inflammation; Male; Postoperative Complications; Thiazines; Thiazoles | 2015 |
Response to letter from Dr Freeman.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Clonixin; Female; Horse Diseases; Inflammation; Male; Postoperative Complications; Thiazines; Thiazoles | 2015 |
Excretory, Secretory, and Tissue Residues after Label and Extra-label Administration of Flunixin Meglumine to Saline- or Lipopolysaccharide-Exposed Dairy Cows.
Topics: Adipose Tissue; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Clonixin; Drug Labeling; Drug Residues; Female; Inflammation; Kidney; Lipopolysaccharides; Liver; Milk; Muscle, Skeletal; Sodium Chloride; Veterinary Drugs | 2015 |
Distribution of Flunixin Residues in Muscles of Dairy Cattle Dosed with Lipopolysaccharide or Saline and Treated with Flunixin by Intravenous or Intramuscular Injection.
Topics: Animals; Anti-Inflammatory Agents; Cattle; Cattle Diseases; Clonixin; Drug Residues; Inflammation; Injections, Intramuscular; Injections, Intravenous; Lipopolysaccharides; Muscle, Skeletal; Sodium Chloride; Veterinary Drugs | 2016 |
In vivo characterization of inflammatory biomarkers in swine and the impact of flunixin meglumine administration.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigens, CD1; Biomarkers; Caspase 1; CD4 Antigens; Chemokine CCL2; Clonixin; Dinoprostone; Enzyme-Linked Immunosorbent Assay; Inflammation; Lipopolysaccharides; Male; Real-Time Polymerase Chain Reaction; Serum Amyloid A Protein; Swine; Swine Diseases; Thromboxane B2 | 2012 |
Ethyl pyruvate diminishes the inflammatory response to lipopolysaccharide infusion in horses.
Topics: Actins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Temperature; Clonixin; Female; Gene Expression Regulation; Horse Diseases; Horses; Inflammation; Interleukin-6; Interleukin-8; Lipopolysaccharides; Male; Pyruvates; Tumor Necrosis Factor-alpha | 2013 |
Evaluation of the ability of carprofen and flunixin meglumine to inhibit activation of nuclear factor kappa B.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Cell Line; Clonixin; Cyclooxygenase Inhibitors; Enzyme Induction; Inflammation; Inhibitory Concentration 50; Lipopolysaccharides; Macrophages; Mice; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Phenylbutazone; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Sheep | 2003 |
Flunixin inhibits prostaglandin E2 production in equine inflammation.
Topics: Animals; Carrageenan; Clonixin; Depression, Chemical; Dinoprostone; Disease Models, Animal; Exudates and Transudates; Female; Horse Diseases; Horses; Inflammation; Male; Nicotinic Acids; Prostaglandins E; Proteins; Time Factors | 1984 |
Non-steroidal anti-inflammatory agents in the horse.
Topics: Animals; Anti-Inflammatory Agents; Clonixin; Horse Diseases; Horses; Inflammation; Meclofenamic Acid; Naproxen; Phenylbutazone | 1981 |
Determination of pharmacokinetics and pharmacodynamics of flunixin in calves by use of pharmacokinetic/pharmacodynamic modeling.
Topics: Acid Phosphatase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Clonixin; Cross-Over Studies; Cysteine Endopeptidases; Exudates and Transudates; Glucuronidase; Inflammation; L-Lactate Dehydrogenase; Lysosomes; Metabolic Clearance Rate; Metalloendopeptidases; Models, Biological; Serine Endopeptidases | 1995 |
Comparative study of the action of flunixin meglumine and tolfenamic acid on prostaglandin E2 synthesis in bovine inflammatory exudate.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cattle; Clonixin; Dinoprostone; Disease Models, Animal; Exudates and Transudates; Inflammation; Male; ortho-Aminobenzoates; Random Allocation | 1994 |
Comparison of the anti-inflammatory actions of flunixin and ketoprofen in horses applying PK/PD modelling.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Clonixin; Cross-Over Studies; Dinoprostone; Exudates and Transudates; Glucuronidase; Half-Life; Horses; Inflammation; Ketoprofen; Leukotriene B4; Male; Models, Biological; Thromboxane B2 | 1995 |
Reversal by naloxone of the spinal antinociceptive actions of a systemically-administered NSAID.
Topics: Analgesics, Opioid; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Clonixin; Dose-Response Relationship, Drug; Electrophysiology; Excipients; Fentanyl; Inflammation; Male; Naloxone; Narcotic Antagonists; Rats; Rats, Wistar | 1996 |
Preliminary pharmacokinetic and pharmacodynamic studies on flunixin meglumine in donkeys.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Clonixin; Dinoprostone; Equidae; Female; Inflammation; Metabolic Clearance Rate | 1996 |
Measurement of cyclooxygenase inhibition in vivo: a study of two non-steroidal anti-inflammatory drugs in sheep.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Clonixin; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diffusion Chambers, Culture; Dinoprostone; Inflammation; Isoenzymes; Leukocyte Count; Leukotriene B4; Male; Phenylbutazone; Prostaglandin-Endoperoxide Synthases; Sheep; Skin Temperature; Thromboxane B2 | 1998 |
Pharmacokinetic studies of flunixin meglumine and phenylbutazone in plasma, exudate and transudate in sheep.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Carrageenan; Clonixin; Cross-Over Studies; Exudates and Transudates; Half-Life; Inflammation; Injections, Intravenous; Male; Oxyphenbutazone; Phenylbutazone; Sheep | 1998 |
Measurement of flunixin in equine inflammatory exudate and plasma by high performance liquid chromatography.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Chromatography, High Pressure Liquid; Clonixin; Exudates and Transudates; Horse Diseases; Horses; Inflammation; Nicotinic Acids | 1987 |
Effects of flunixin meglumine and dexamethasone on aqueous protein values after intraocular surgery in the dog.
Topics: Animals; Aqueous Humor; Clonixin; Dexamethasone; Dog Diseases; Dogs; Drug Therapy, Combination; Eye Proteins; Inflammation; Nicotinic Acids; Ophthalmologic Surgical Procedures; Postoperative Complications; Random Allocation | 1987 |